Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline - An open clinical trial

Sleep

Volumn 23, Issue 3, 2000, Pages 349-354

  Stiasny, Karin ^a   Röbbecke, Julia ^b   Schüler, Peter ^b   Oertel, Wolfgang H ^b  

^a Center of Nervous Diseases   (Germany)

^b NONE

Author keywords

Augmentation; Cabergoline; Dopamine agonists; Levodopa; Periodic leg movements (PLM); Restless legs syndrome (RLS); Therapy

Indexed keywords

CABERGOLINE; DOMPERIDONE; LEVODOPA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME;

EID: 0342699463     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/23.3.1b     Document Type: Article

References (16)

1. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10(5):634-42.
2. Pollmächer T, Schulz H. Periodic leg movements (PLM): their relationship to sleep stages. Sleep 1993;16(6):572-7.
3. Trenkwalder C, Stiasny K, Pollmächer T, Wetter TC, Schwarz J, Kohnen R, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 1995;18(8):681-8.
4. Collado-Seidel V, Kazenwadel J, Wetter TC, Kohnen R, Winkelmann J, Selzer R, et al. A controlled study of additional SR-L-dopa in L-dopa responsive RLS with late night symptoms. Neurology 1999;52:285-290.
5. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996;19(3):205-13.
6. Winkelmann J, Wetter TC, Stiasny K, Oertel WH, Trenkwalder C. Treatment of restless leg syndrome with pergolide - an open clinical trial. Mov Disord 1998;13(3):566-9.
7. Wetter TC, Stiasny K, Winkelmann J, Buhlinger A, Brandenburg U, Penzel T, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999;52:944-950.
8. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles, CA: UCLA Brain Information Service/Brain Research Institute, 1968.
9. Atlas Task Force of the American Sleep Disorders Association. Guilleminault C, chairman. EEG arousals: scoring rules and examples. Sleep 1992;15:173-184.
10. Atlas Task Force of the American Sleep Disorders Association. The international classification of sleep disorders - diagnostic and coding manual; 1997:65-68.
11. National Institute of Mental Health, editor. 12 -CGI. Clinical Global Impressions. Chevy Chase, MD: 1970.
12. Kramer C, Kerekjarto M, Leplow B, Krasemann EO. Lebensqualitätsmessungen im wöchentlich erhobenen Verlauf bei Herzinfarktpatienten. Psychother Psychosom Med Psychol 1990;40:409-416.
13. Guilleminault C, Cetel M, Philip P. Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 1993;43(2):445.
14. Silber MH, Shepard JW, Jr., Wisbey JA. Pergolide in the management of restless legs syndrome: an extended study. Sleep 1997;20(10):878-82.
15. Earley CJ, Allen RP. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1996;19(10):801-10.
16. Rinne U, Bracco F, Chouza C, Dupont E, Gershanik O, Marti-Masso JF, et al. Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. Drugs 1998;55(Suppl. 1):23-30.